Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jun;5(6):461-462.
doi: 10.1016/S2213-2600(17)30166-2. Epub 2017 May 5.

Antibiotics for COPD exacerbations

Affiliations
Comment

Antibiotics for COPD exacerbations

Wassim W Labaki et al. Lancet Respir Med. 2017 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Nouira S, Marghli S, Belghith M, Besbes L, Elatrous S, Abroug F. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet. 2001;358(9298):2020–5. doi: 10.1016/S0140-6736(01)07097-0. - DOI - PubMed
    1. Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA. Antibiotics for exacerbations of chronic obstructive pulmonary disease. The Cochrane database of systematic reviews. 2012;12:CD010257. doi: 10.1002/14651858.CD010257. - DOI - PubMed
    1. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of internal medicine. 1987;106(2):196–204. - PubMed
    1. Llor C, Moragas A, Hernandez S, Bayona C, Miravitlles M. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2012;186(8):716–23. doi: 10.1164/rccm.201206-0996OC. - DOI - PubMed
    1. Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014;384(9944):691–702. doi: 10.1016/S0140-6736(14)61136-3. - DOI - PMC - PubMed

Substances